Det lille salget blir vel brukt til et stort julebord
Ultimovacs enters next step in new vaccine platform development - BioStock
Ultimovacs’ TENDU trial is a clinical phase I study aimed at testing the company’s TET platform for cancer vaccine development in prostate cancer patients.
Est. reading time: 4 minutes